Caricamento...
Antithrombotic therapy in diabetes: which, when, and for how long?
Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, contributes to the high vascular risk in individual...
Salvato in:
| Pubblicato in: | Eur Heart J |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203081/ https://ncbi.nlm.nih.gov/pubmed/33764414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehab128 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|